CD4 and neoplasm: In 94 patients with OSCC, a higher density of CD3+ T cells in both the invasive margin (IM) and center of the tumor (CT) were associated with lower stage (T1 and T2 tumors) and increased CD8+ and CD4+ T cells in the invasive margin predicted lower risk of axillary metastases [3].